Biotechs desperate to partner as other funding sources dry up With the capital markets closed, partnering is currently the only way for development–stage biotechs to stay in business. 18 Nov 2008 News
Pipeline is fixed, says Novartis Two years after reforming its R&D process, pharma giant Novartis says it has seen a 40 per cent increase in productivity. 18 Nov 2008 News